Newsroom

U.S. Representatives Cliff Bentz and Jared Golden have reintroduced the Patients’ Right to Know Their Medication Act (HR 5133) to ensure all Americans receive printed medication information with prescriptions. This bipartisan bill aims to improve patient safety, particularly in rural areas with limited access to internet and pharmacists, by mandating FDA-approved Patient Medication Information. Read More

The Seattle Times recently highlighted the impact of drugstore closures in the Pacific Northwest, focusing on Bartell Drugs. The Pharmaceutical Printed Literature Association warns that a proposed FDA regulation could worsen pharmacy access, increasing burdens on pharmacists and risking patient safety by shifting the responsibility for medication information to them. Read More

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the retention of printed Prescribing Information (PI) and Patient Medication Information (PMI) amidst proposed FDA rules that could limit access. They emphasize that printed materials are vital for rural Americans lacking digital access, urging the Trump administration to protect these resources to ensure medication safety and… Read More

The Pharmaceutical Printed Literature Association (PPLA) urges Dr. Marty Makary to prioritize patient safety by reversing harmful FDA regulations on printed medication information if confirmed as commissioner. The proposed rules threaten crucial printed instructions for patients and pharmacists, compromising care and safety. PPLA advocates for accessible medication literature to enhance patient involvement. Read More

Following President Trump’s inauguration, PPLA Chairman Dave Joesten urged nominees Robert F. Kennedy Jr. and Dr. Marty Makary to rescind proposed FDA rules that would limit printed Prescribing and Patient Medication Information. These rules threaten patient safety, particularly for vulnerable populations, while a bipartisan coalition supports legislation for accessible printed information. Read More